MedPath

Regulation of DNA methylation modification of Mesenchymal Stem Cells by Kidney-marrow Simultaneous Therapy in the treatment of osteoarthritis

Not Applicable
Conditions
Osteoarthritis
Registration Number
ITMCTR2000003227
Lead Sponsor
First affiliated hospital of Zhejiang Chinese Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Western medicine diagnosis: in 2018, the Chinese society of bone sciences revised the KOA clinical diagnostic criteria;
2. The average age of KOA patients was between 55 and 75 years old and required knee replacement.

Exclusion Criteria

1. With other diseases affecting bone metabolism;
2. With rheumatoid diseases, such as systemic diseases, spondylitis or rheumatoid arthritis;
3. With a history of severe joints.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Imaging;WOMAC score;VAS score;Dnmt3b expression;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath